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Introduction
During embryogenesis, hematopoietic development is spa-
tiotemporally organized in different waves. During the first,
so-called ‘primitive’ wave of hematopoiesis, nucleated ery-
throcytes and macrophage-like cells are generated in the yolk
sac (YS). Subsequent waves generate multipotent progenitor
cells, first in the YS and, finally, in the aorta-gonado-
mesonephros region (AGM) where hematopoietic stem cells
(HSCs) are generated.1 
Members of the MYB transcription factor family are impor-
tant transcriptional regulators throughout embryonic devel-
opment. One of these three family members, MYB, is differ-
entially expressed during embryonic hematopoietic develop-
ment.2 While Myb transcripts have been detected at low levels
during early waves of hematopoiesis, this process is not
MYB-dependent. In contrast, HSC-dependent hematopoiesis
appears to strictly rely on MYB as loss of function mutants of
MYB lead to embryonic lethality due to failure of fetal liver
hematopoiesis.3,4 In the zebrafish, transgenic animals express-
ing eGFP under control of myb regulatory elements have been
used for visualization and analysis of HSC generation from
aortic blood forming hemogenic endothelium.5
In postnatal life, long-term repopulating hematopoietic
stem cells (LT-HSC) were found to express the highest levels
of Myb and levels decrease progressively in the short-term
repopulating HSC (ST-HSC) and in the multipotent progeni-
tor population (MPP).6,7 
MYB-independent hematopoiesis consists largely of short-
lived precursors and mature blood cells. However, the
mononuclear phagocyte system (MPS), consisting of brain
microglial cells, hepatic Kupffer cells and skin Langerhans
cells, seems to be derived from MYB-independent
hematopoietic progenitor cells (HPC) rather than bone mar-
row-derived MYB-dependent HSC. Recently, Schulz and col-
leagues have shown that two parallel pathways of
macrophage differentiation can be distinguished by their
inherent dependence on MYB.8 MYB-independent cells origi-
nate in the YS around embryonic day 7.5-8.5 (E7.5-E8.5), pos-
sibly from an erythro-myeloid restricted precursor (EMP),
while MYB-dependent macrophages originate from bone
marrow HSC.  
Gene therapeutic strategies for inherited immune deficien-
cies or other genetic diseases of the blood rely on the assump-
tion that HSC can be generated in vitro from pluripotent stem
cells.9 In these approaches, patient-specific induced pluripo-
tent stem cells are generated and the defective gene is correct-
ed by homologous recombination subsequent to targeting the
gene defect by zinc-finger nucleases (ZFN) or TALENs. Once
the genetic defect is corrected, ‘cured’ HSC are generated by
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Although hematopoietic precursor activity can be generated in vitro from human embryonic stem cells, there is no
solid evidence for the appearance of multipotent, self-renewing and transplantable hematopoietic stem cells. This
could be due to short half-life of hematopoietic stem cells in culture or, alternatively, human embryonic stem cell-
initiated hematopoiesis may be hematopoietic stem cell-independent, similar to yolk sac hematopoiesis, generat-
ing multipotent progenitors with limited expansion capacity. Since a MYB was reported to be an excellent marker
for hematopoietic stem cell-dependent hematopoiesis, we generated a MYB-eGFP reporter human embryonic
stem cell line to study formation of hematopoietic progenitor cells in vitro. We found CD34+ hemogenic endothelial
cells rounding up and developing into CD43+ hematopoietic cells without expression of MYB-eGFP. MYB-eGFP+
cells appeared relatively late in embryoid body cultures as CD34+CD43+CD45-/lo cells. These MYB-eGFP+ cells were
CD33 positive, proliferated in IL-3 containing media and hematopoietic differentiation was restricted to the gran-
ulocytic lineage. In agreement with data obtained on murine Myb-/- embryonic stem cells, bright eGFP expression
was observed in a subpopulation of cells, during directed myeloid differentiation, which again belonged to the
granulocytic lineage. In contrast, CD14+ macrophage cells were consistently eGFP– and were derived from eGFP-
precursors only. In summary, no evidence was obtained for in vitro generation of MYB+ hematopoietic stem cells
during embryoid body cultures. The observed MYB expression appeared late in culture and was confined to the
granulocytic lineage.  
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ABSTRACT
an appropriate in vitro differentiation protocol before infu-
sion. However, current protocols have failed to convinc-
ingly demonstrate the generation of HSC in pluripotent
stem cell differentiation cultures. 
To investigate whether during in vitro human embryonic
stem cell (hESC)-derived hematopoiesis HSC are formed
or rather hematopoiesis from hESC depends on the emer-
gence of a MYB independent EMP-like cell, we generated
a MYB reporter line using random integration of a bacter-
ial artificial chromosome (BAC) reporter construct in
which eGFP expression is under control of the MYB regu-
latory DNA sequences. 
Methods
Cell lines, culture of cell lines and isolation of primary
cells
All experiments were approved by the Medical Ethical
Committee of Ghent University Hospital, Belgium.  The WA01
(National Institutes of Health code: WA01) human embryonic
stem cell (hESC) line was used in all experiments. A detailed
description of the methods used for cells and cell cultures is avail-
able in the Online Supplementary Appendix. 
Hematopoietic differentiation of hESC in spin embryoid
bodies 
To differentiate hESC into hematopoietic cells, the protocol
from Ng et al. was used with minor modifications.10 In brief, 5x103
single cell-adapted hESC were spun at 480 g into each well of 96-
well low attachment plates and subsequently cultured in APEL
medium containing 10 mM Rock inhibitor Y-27632 (Selleckchem,
Houston, TX, USA), 40 ng/mL SCF (Peprotech, Rocky Hill, NJ,
USA), 2 ng/mL BMP4 (R&D, Minneapolis, MN, USA) and 20
ng/mL VEGF165 (Peprotech), further referred to as “embryoid
body (EB) mix”. After four days, spin EB were transferred onto an
OP9 cell layer and further cultured in EB mix for a total of 7-14
days. Half of the medium was changed on day 7 (d7), with APEL
medium containing EB mix cytokines, unless a different combina-
tion of cytokines is specified. These cytokines were added at the
following concentrations: 50 ng/mL IL-3 (R&D), 50 ng/mL Flt3-L
(R&D), 10 ng/mL TPO (Peprotech) and/or 50 ng/mL IL-6 (R&D). 
For myeloid differentiation, spin EBs were dissociated at d11
and transferred onto OP9 cells in MEM-a with 20% FCS, supple-
mented with 50 ng/mL SCF (Peprotech), 50 ng/mL TPO
(Peprotech), 10 ng/mL IL-3 (R&D) and 20 ng/mL IL-6 (R&D). For
erythro-megakaryocytic differentiation, spin EBs were dissociated
and transferred onto OP9 cells in MEM-a with 20% FCS, supple-
mented with 50 ng/mL SCF (Peprotech), 50 ng/mL TPO
(Peprotech) and 50 ng/mL EPO (eBioscience, San Diego, CA,
USA). 
Flow cytometry and cell sorting
Flow cytometric analysis was performed on an LSR II system
(BD Biosciences, San Jose, CA, USA). Cell sorting was performed
with a FACS ARIA IIIU system (BD Biosciences). A list of the anti-
bodies used can be found in the Online Supplementary Appendix. 
Real-time RT-qPCR
Cells were lysed and cDNA was synthesized using the SYBR
power cells-to-Ct system (Ambion, Life Technologies, Carlsbad,
CA, USA) according to the manufacturer’s instructions. Primer
sequences can be found in Online Supplementary Table S1. PCR
reagents and SYBR GreenI master were obtained from Roche
(Roche, Penzberg, Germany) and used according to the manufac-
turer’s instructions. The reactions were run on a lightcycler480
384-well system (Roche). 
Statistical analysis
All statistical analyses were performed using SPSS v.22.0 (IBM,
New York, NY, USA). Significance was assessed using Mann-
Whitney U statistical analysis; P≤0.05 was considered significant.
Additional information on materials and methods is provided in
the Online Supplementary Appendix.  
Results
Generation of MYB-eGFP transgenic reporter hESC
To study MYB expression during hematopoietic differ-
entiation, we generated a MYB-eGFP reporter hESC line
using random insertion bacterial artificial chromosome
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Figure 1. Functional validation of MYB-eGFP
reporter hESC. (A) MYB FISH analysis (green)
on metaphase nuclei (DAPI stain in gray); inset
shows chromosome 11 only. (B) ArrayCGH
showing amplification of the genomic region
within the BAC plasmid. A relevant portion of
chromosome 6 is shown. (C) Validation of
selection cassette removal, as assessed by
PCR ranging from eGFP to the first exon of
MYB (upper gel) or ranging from pPGK to the
first exon of MYB (lower gel). (D) MYB-eGFP
reporter hESCs differentiated towards the
hematopoietic lineage were analyzed for eGFP
expression. CD34+CD43– endothelial and
CD43+ hematopoietic populations are depict-
ed. Both floxed and non-floxed cell lines are
shown. (E) Confocal fluorescence microscopy
of a day 20 embryoid bodies (EB) culture in EB
mix showing bright eGFP positive round cells.
Scale bar measures 100 mM. (F) MYB qPCR
analysis of eGFP sorted hematopoietic cells
from EB differentiation culture. Expression is
shown relative to the mean of GAPDH and
YWHAZ expression. Error bars indicate stan-
dard deviation (SD) of the mean (n=4). 
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Figure 2. MYB-eGFP+ HPC are generated relatively late in
embryoid bodies cultures. (A) Gating strategy for assess-
ment of eGFP expression, a representative plot of embryoid
bodies (EB) day 11 (d11) culture is shown. (B) Flow cyto-
metric analysis of d11 and d14 EB cultures in EB mix. Wild-
type hESC are presented as control for eGFP signal in all
populations. Percentages of cells in each quadrant are
shown.  
Figure 3. Hematopoietic cells are generated directly from hemogenic endothelium, without an eGFP+ intermediate. Time-lapse confocal analy-
sis of re-plated day 11 (d11) hemogenic endothelium. A single frame is depicted every 2 h starting from the defined starting point. Cropped
images are shown for every channel. Arrows depict a single endothelial cell at the starting point of analysis and the progeny thereof at later
points in time. Scale bar measures 100 mM. At 72 h, the cells have rapidly proliferated and generated two clusters of 8 cells. These cells have
down-regulated CD34 and up-regulated CD43. Scale bar measures 100 mM.
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(BAC) transgenesis (Online Supplementary Figure S1). 
After nucleofection of hESC and neomycin selection,
neomycin-resistant hESC colonies were obtained. Figure 1
shows data for clone 5, which gave the highest eGFP
expression and was used in all experiments. Besides the
endogenous MYB loci on chromosome 6q, a clear
hybridization signal on chromosome 11q was detected on
FISH analysis, confirming successful integration of the
BAC reporter vector (Figure 1A). High-resolution
arrayCGH shows integration of the BAC plasmid from
+84.6 kbp 5’ of the MYB start codon to -39.3 kbp 3’ of the
start codon. This region encompasses the complete MYB
gene and upstream regulatory elements (Figure 1B).
Hematopoietic differentiation of the MYB-eGFP cell
line, before removal of the selection cassette, showed
eGFP expression by CD43+ hematopoietic cells as well as
by CD34+CD43– endothelial cells (Figure 1D). As no MYB
transcripts could be found by qPCR analysis in the
CD34+CD43– population (Online Supplementary Figure S2),
aberrant expression due to interference of the pGK pro-
motor was hypothesized. Therefore, the pGK promotor-
driven selection cassette was removed through transient
transfection with a Cre recombinase-encoding plasmid
(Figure 1C). After removal of the selection cassette, no
eGFP expression was observed in non-hematopoietic cells
(Figure 1D). Although the expression of eGFP found at this
point in time was relatively weak, prolonged culture clear-
ly showed strong eGFP+ cells as determined by confocal
microscopy analysis of d20 EB differentiation cultures
(Figure 1E). 
Fidelity of the random integration reporter cell line was
validated by qPCR analysis for MYB expression. eGFP-,
eGFPlow and eGFPhi cells were sorted from d14 hematopoi-
etic differentiation cultures in the presence of SCF, TPO,
IL-3 and IL-6 and MYB mRNA levels were shown to cor-
relate with eGFP protein expression in the sorted popula-
tions (Figure 1F and Online Supplementary Figure S2). Note
that the eGFP– cells are not completely negative for MYB
mRNA. This indicates that the reporter line is not as sen-
sitive as RT-qPCR for MYB expression. However, this
does not preclude the detection of HSC, as these cells are
supposed to express high levels ofMyb.6
Endothelium-derived early hematopoietic precursors
are MYB-eGFP negative
Spin EB cultures were set up and screened daily for the
appearance of hematopoietic eGFP+ cells. Expression of
CD43, the earliest marker for hematopoietic cells, was
first observed in our cultures at d7. Few eGFP+ cells
became apparent from d11 onwards, forming a clear pop-
ulation on d14. As shown in Figure 2A and B, these eGFP+
cells were contained within the CD34+ CD43+ population,
which has been reported to contain progenitors of multi-
ple hematopoietic lineages. On the other hand, the CD34+
CD43- endothelial and CD34+ CD43lo emerging HPC pop-
ulations were consistently negative for eGFP expression
(Figure 2B). As expression was also found highest in the
CD34+ CD43+ population within the CD45low population
(Online Supplementary Figure S2), we hypothesized this
population to have the highest possibility of containing
MYB+ multipotent progenitors.
To assess whether the eGFP+ CD43+ hematopoietic cells
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Figure 4. Characterization of MYB-eGFP+ HPC. (A) Absolute cell number of eGFP+ cells within the CD34+CD43+ population of day 14 (d14)
embryoid bodies (EB) cultures. Error bars indicate standard deviation (SD) of the mean (n=3). (B) Flow cytometric analysis of d14 MYB-eGFP
EB, cultured in the presence of different cytokine mixes as indicated. Dot plots are gated on CD34+CD43+. Cells within the eGFP+ gate are
depicted in the histograms. Shaded histograms show isotype control stained samples for the indicated marker. Representative plots of 3 inde-
pendent experiments are shown. 
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were emerging directly from hemogenic endothelium, d11
CD34+ CD43– endothelial cells were sorted and re-plated
on OP9 stromal cells in medium containing SCF, BMP4
and VEGF. After six days of culture, a distinct CD45+ pop-
ulation was apparent; however, no eGFP+ cells were seen
at this time point. After 11 days of culture, eGFP+ cells
became apparent (Online Supplementary Figure S3). As this
assay might miss the emergence of transient eGFP+ cells
directly from hemogenic endothelium, we used a similar
set-up to analyze the emergence of hematopoietic cells
from endothelium by live confocal imaging. During live
confocal imaging, adherent eGFP–CD34+ CD43– endothe-
lial cells were found to round up and form cells with
hematopoietic appearance. These cells subsequently up-
regulated CD43 and proliferated extensively over the
course of 72 h. We could not detect eGFP expression dur-
ing the whole process of blood cell generation and subse-
quent proliferation, suggesting MYB-independent genera-
tion of HPC (Figure 3 and Online Supplementary Movie S1).
Similar experiments initiated with sorted eGFP–CD34+
CD43– endothelial cells derived from earlier (d7) or later
(d14) time points of EB cultures were much less potent in
the generation of hematopoietic cells and generated only a
few blood cells. 
To verify whether other or additional growth factors
were required for the generation and/or expansion of the
eGFP+ CD34+ CD43+ CD45–/lo population, EB-derived
hematopoietic cells were cultured in different cytokine
combinations of SCF, TPO, Flt3-L, IL-3 and IL-6. It was
found that eGFP+ CD34+ CD43+ CD45–/lo cells expanded
most efficiently in conditions containing IL-3. As shown in
Figure 4A, the mean of absolute numbers of eGFP+ CD34+
CD43+ CD45–/lo per EB was approximately 6-fold higher
than those in conditions without IL-3. This suggests that
the eGFP+ CD34+ CD43+ CD45–/lo cells are responsive to IL-
3, as reported previously.11
Characterization of eGFP negative and eGFP positive
subsets
To further define the eGFP+ cells generated in these cul-
tures, we analyzed these cells for expression of the stem
cell phenotype CD38–, CD90+, CD49f+ and CD45RA– as
previously described by Notta et al., the myeloid lineage
markers CD33 and CD123, and erythro-megakaryocytic
lineage markers CD41a and CD235a. As shown in Figure
4B, eGFP+CD34+CD43+CD45–/lo cells expressed low levels
of CD45RA, were negative for CD38 and CD90, and
expressed CD49f. This CD34+CD45RA–CD38–CD49f+
phenotype was present in all conditions, including the
conditions containing IL-3, and is similar to the long-term
In vitro hESC hematopoiesis independent of MYB
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Figure 5. MYB–eGFP+ HPC show commit-
ment towards the granulocytic lineage. (A)
Flow cytometric analysis of differentiation
cultures towards granulocytic, monocytic,
megakaryocytic and erythroid cells. Day 14
(d14) MYB-eGFP hESC-derived precursors
with indicated phenotypes were isolated
from IL-3 and Flt3-L expanded EB; represen-
tative plots of at least 3 independent experi-
ments are shown. (B) qPCR analysis for line-
age commitment genes on indicated popula-
tions, isolated from d14 MYB-eGFP hESC EB
expanded in presence in IL-3 and Flt3-L.
Expression is shown relative to the expres-
sion of GAPDH. Error bars indicate standard
deviation (SD) of the mean (n=3). 
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engraftable HSC described by Notta et al.12 However, the
eGFP+ cells in our cultures also showed clear expression of
CD33 and CD123, while erythroid lineage markers were
negative, suggesting myeloid lineage commitment of
these cells. The phenotype was very similar regardless of
the cytokines added, except for the condition in EBmix +
TPO + Flt3-L, where CD38 was up-regulated. CD235 and
CD41a were consistently absent on these populations,
arguing against erythroid commitment of
eGFP+CD34+CD43+CD45–/lo cells. 
The eGFP–CD34+CD43+CD45– cells, on the other hand,
contained mainly erythroid-committed cells, while the
CD45+ population consisted of cells expressing myeloid
lineage markers (data not shown). The eGFP+ cells derived
from eGFP– hemogenic endothelium, also phenotyped as
CD45lowCD33+CD14– cells, consistent with the data
obtained on bulk cultures (Online Supplementary Figure
S3B).
We assessed myeloid, erythroid and megakaryocytic
differentiation capacity of the different populations
obtained in the cultures with various growth factor mixes
to assess multipotency. Results were qualitatively similar
for all growth factor conditions. Figure 5A shows the
results of sorted cell populations from d14 spin EB cultures
expanded with EBmix plus IL-3 and Flt3-L, and subse-
quently assayed under conditions optimal for either
myeloid, erythroid or megakaryocytic differentiation. The
eGFP–CD34+CD43+CD235a/CD41a–CD45– population
clearly contained progenitors giving rise to myeloid, ery-
throid and megakaryocytic cells, while the
eGFP+CD34+CD43+CD235a/CD41a–CD45–/lo population
was shown to give rise to granulocytic lineage myeloid
cells only, with a complete absence of monocytic, ery-
throid and megakaryocytic precursor potential. On the
other hand, eGFP–CD34+CD43+CD235a/CD41a+ cells gave
rise mainly to erythroid and megakaryocytic cells,
although some myeloid precursor activity was also
observed. eGFP–CD34+CD43+CD235a/CD41a–CD45+ cells
were able to give rise to CD11b+CD14– granulocytic line-
age cells, CD11b+CD14+ macrophage lineage cells,
CD71+CD235+ erythroid and CD41+ megakaryocytic cells
(Figure 5A).  
To assess expression of genes associated or determining
commitment towards the different lineages, RT-qPCR was
performed for MPO, GATA1, PU.1 and MPL on the same
sorted populations as in Figure 5A. MYB was assessed as
a control and, as expected, showed high expression in the
eGFP+ population (Figure 5B). In line with the multipotent
precursor capacity, the eGFP–CD34+CD43+CD45– cells
expressed only low levels of the various genes analyzed.
In contrast, the eGFP–CD34+CD43+CD45+ cells had signif-
icantly higher levels of PU.1 suggesting that, together with
the acquisition of CD45, the cells become committed to
the macrophage lineage.  As expected, the
eGFP–CD34+CD235a/CD41a+ express high levels of
GATA1 and MPL, emphasizing their erythro-megakary-
ocytic commitment. In contrast, the
eGFP+CD34+CD43+CD45–/lo cells show high expression of
MPO and low levels of PU.1 suggestive for granulocytic
lineage commitment. GATA1 expression was also detected
in the eGFP+CD34+CD43+CD45–/lo population, in agree-
ment with granulocytic lineage commitment
To study the generation of the eGFP+ precursor at the
clonal level, CFU assays and single cell sorting followed
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Figure 6. Clonal progeny analysis of CD34+CD43+ progenitors. (A) Representative microscopic images of eGFP–CD34+CD43+ day 11 (d11)
embryoid bodies (EB) derived progenitor CFU assay, analyzed after 14 days of liquid culture. A representative image for each colony type is
depicted. Both eGFP and brightfield channels are shown. (B) Representative analysis of single cell (clonal) cultured CD34+CD43+ EB derived
progenitors, analyzed after seven days of culture. CD235a/CD41a– cells are depicted in the center and right panels. Scoring gates are indicat-
ed with E (erythroid/megakaryocytic), M (monocytic) and G (granulocytic). Combination of these gates led us to determine colony type as G,
M, E, GM or GEMM as indicated for the representative plots. Representative progeny of eGFP+CD34+CD43+ EB derived progenitors are depicted
in the dotted box. (C) Frequency of progenitor types within CD34+CD43+ EB derived progenitors at the indicated time points. Absolute numbers
of colonies are indicated between brackets. The progeny of eGFP–CD34+CD43+ are depicted in the panels below as fractions of wells containing
eGFP+ cells or wells lacking eGFP+ cells. At d14, progeny of the eGFP+CD34+CD43+ population was assayed, next to the progeny of
eGFP–CD34+CD43+ progenitors. All wells were scored as shown in (B).  
A B C
by liquid culture were performed on d11 and d14 EB cul-
tures (Figure 6). The d11 eGFP–CD34+CD43+ cell popula-
tion gave rise to CFU-GEMM, CFU-GM, CFU-G, CFU-
M, BFU-E and CFU-E. These colonies were analyzed
microscopically for eGFP expression and it was observed
that the CFU-GM, CFU-G and CFU-GEMM contained
eGFP positive cells whereas the CFU-M, CFU-E and BFU-
E were consistently negative (Figure 6A). Similarly, using
single-cell culture and flow cytometric analysis, we
found that d11 and d14 eGFP–CD34+CD43+ progenitors
consisted of GEMM, GM, G, M, E precursors. A marked
skewing towards the myeloid lineage was observed on
d14 of culture. In agreement with the CFU assays, eGFP+
cell containing wells were confined to the wells contain-
ing G, GM and GEMM precursor cells, whereas the wells
lacking eGFP expression contained E and M precursors
(Figure 6B and C). These data clearly show that the
MYB-eGFP+ precursor is a more committed myeloid pre-
cursor derived from a multipotent MYB-eGFP–
hematopoietic precursor cell.
While macrophage development is MYB-independent,
MYB marks granulocytic lineage differentiation 
As MYB was described to be dispensable for the gener-
ation of YS-derived macrophages, we studied the role of
MYB during myeloid lineage choice. When EB cultures
were grown under myeloid differentiation conditions, a
homogenous population of CD45+CD33+ was obtained
after four days of culture (Figure 7A). To further define
both eGFP– and eGFP+ populations, we analyzed both
populations by flow cytometry, cytospin and qPCR. 
The eGFP+ population was found to be CD45lo and pos-
itive for CD33, weakly expressing the myeloid markers
CD11c, CD11b, CD123 and CD13. The granulocytic
marker CD15 was found absent. This phenotype is in
line with the surface phenotype of myelocytes, a precur-
sor of the granulocyte lineage. Macrophage markers
CD14, CD16, CD115, HLA-DR and CD86 were consis-
tently negative. On the other hand, the eGFP– population
was found to be CD45hi and CD33+. These cells were
CD11chi, CD11bhi, CD14+, HLA-DR+, CD86+ compatible
In vitro hESC hematopoiesis independent of MYB
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Figure 7. Myeloid cells show strong expression of MYB-eGFP upon granulocytic lineage differentiation. (A) Flow cytometric analysis of myeloid-
directed differentiation of day 11 MYB-eGFP hESC embryoid bodies, after 5 days of myeloid culture. Representative plots of at least 3 inde-
pendent experiments are shown. (B) Phenotypic analysis of eGFP+ (upper panels) and eGFP– (lower panels) populations in myeloid directed dif-
ferentiation cultures of day 11 (d11) MYB-eGFP embryoid bodies after five days of myeloid culture. All cells shown in histograms are gated on
CD45. Shaded histograms show control staining for the depicted marker. Representative plots of 3 independent experiments are shown. 
(C) May-Grünwald-Giemsa staining of cytospin samples of myeloid-directed differentiation of d11 MYB-eGFP hESC embryoid bodies, eGFP-
CD14+CD11b+ and eGFP+CD14– populations are depicted. (D) qPCR analysis for lactoferrin (LTF) and MYB expression in indicated populations.
Expression is shown relative to the mean of GAPDH and YWHAZ expression. Error bars indicate standard deviation (SD) of the mean (n=2).   
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with an activated macrophage phenotype. CD115, the
receptor for M-CSF, was found only weakly positive.
The cells also expressed CD16, a phenotype compatible
with tissue macrophages (Figure 7B).  On cytological
analysis using May-Grünwald-Giemsa staining,
eGFP+CD14– cells show a granulocytic cytoplasm com-
patible with myelocytic granulocyte lineage cells, where-
as the morphology of the eGFP–CD14+ cells is compatible
with tissue macrophages (Figure 7C).  This was con-
firmed by qPCR analysis showing these eGFP+ cells to
express the granule protein lactoferrin (LTF), eGFP– cells,
on the other hand, were devoid of lactoferrin expression
(Figure 7D). As expected, MYB expression levels were
high in eGFP+CD14– cells (Figure 7D). 
To analyze whether the generation of these
macrophages from hematopoietic precursor cells was
MYB-independent, we sorted eGFP–CD34+CD43+CD45+
committed precursor cells, cultured these in myeloid con-
ditions on OP9 stromal cells and analyzed them daily for
the expression of eGFP. After four days, a population of
CD14+ cells was already clearly visible. These cells were
negative for eGFP as assessed by flow cytometry (Figure
8A). Further culture of these cells for up to 11 days showed
clear eGFP positive populations at all analyzed time
points. However, at no time point were eGFP+CD14+ cells
observed. After 11 days of culture, virtually all eGFP– cells
were CD14 positive (Figure 8A). 
To determine whether an eGFP+CD14– intermediate stage
gave rise to the eGFP–CD14+ macrophage cells, sorted d11
eGFP–CD34+CD43+CD45+CD14– committed HPC were cul-
tured under myeloid conditions and analyzed using live
confocal microscopy to track cells becoming CD14+. We did
not observe eGFP expression in cells acquiring CD14
expression (Figure 8B and Online Supplementary Movie S2).
These data suggest that the generation of CD14+
macrophage cells from hESC is MYB-independent. 
Discussion
We here show evidence that multipotent HPCs express-
ing high levels of MYB are not generated in human EB cul-
tures initiated with hESC. We, therefore, conclude that the
hematopoietic cells generated in vitro from hESC, using
current in vitro protocols, emerge through an endothelial
intermediate, and are precursors with limited stem cell
activity that resemble YS hematopoietic progenitors.  In
addition, we show that the first progenitors derived from
endothelial cells are eGFP–CD34+CD43+ cells, which then
develop into eGFP+CD34+CD43+ granulocyte committed
progenitors.
Multipotency and self-renewal are two hallmark charac-
teristics of HSC. With regard to multipotency, almost all
hematopoietic cell types can be generated from hESC-
derived hematopoietic precursors, including erythro-
cytes,13 megakaryocytes,14 granulocytes, monocytes,15 NK
cells16 and T cells.17,18 Although, to our knowledge, it has
not been demonstrated that a single hESC-derived
hematopoietic precursor cell is able to form all of the
aforementioned cell types, the absence of these reports
may be due to technical issues associated with precursor
cells of limited proliferative capacity. The fact that T cells
can be generated from fetal HPC does not in itself prove
the presence of multipotent progenitors or HSC, since it
has been shown that T cells can be generated from YS pre-
cursors that arise before HSC are generated.19,20 Self-
renewal of HSC is evaluated by their ability to reconsti-
tute immune deficient mice. Previous studies have report-
ed re-population by in vitro hESC-derived HPC.21,22 Wang et
al. reported multilineage hematopoietic repopulation
upon intrafemoral injection of HPC.22 However, hESC-
derived HPCs had limited proliferative and migratory
capacity compared with somatic HSCs. In another study
by Ledran et al., whole hESC differentiation co-cultures
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Figure 8. Macrophages develop without
expression of MYB-eGFP and show charac-
teristics of yolk sac-derived tissue
macrophages. (A) Flow cytometric analysis
of myeloid-directed differentiation of day
11 (d11) MYB-eGFP hESC embryoid bod-
ies (EB)-derived eGFP–CD34+CD43+CD45+
precursors, after 4, 8 and 11 days of
myeloid culture. (B) Time-lapse confocal
analysis of live stained cultures.
eGFP–CD34+CD43+CD45+CD14– cells were
cultured in myeloid differentiation condi-
tions. Samples were live stained with
CD14–PE for confocal analysis. eGFP+
myeloid cells are shown as reference.
Single channel panels are shown every
hour starting from 11.30 h after plating
onwards. Scale bars measure 10 mM.
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with stromal cells derived from murine fetal tissues were
injected intrafemorally in mice. These cells were reported
to re-populate bone marrow of the non-injected femur as
well as the spleen. In addition, secondary engraftment was
reported. However, the engrafted cells were not fully
defined. The phenotype shown is compatible with
myeloid cells (CD33+CD13+). As it is known that tissue
macrophages have a long lifespan, and are found lifelong
in the adult, without a need for HSC to replenish them,
chimerism may have been caused by cells that are not
HSC dependent. There was no evidence for engraftment
of CD34+ cells in the bone marrow.
In a recent article by Amabile et al., hESC were injected
in mice to form teratoma. The authors show that in these
teratoma, also hESC derived CD34+ hematopoietic cells
are formed. Upon isolation and transplantation of these
CD34+ HPC into immunodeficient mice, engraftment of
human cells was found, including CD34+ cells in the bone
marrow. This in vivo differentiation model, therefore, sug-
gests that HSC can be generated from human pluripotent
stem cells.23 
In conclusion, based on these data, it remains question-
able whether HSC can be formed from ESC using current-
ly available in vitro differentiation protocols, although it is
clear that multipotent progenitors are formed. Changes to
the culture conditions, such as other cytokine mixtures or
the use of more appropriate feeder lines may result in HSC
generation. The MYB-eGFP cell line that we generated
will be very helpful in screening for such conditions. We
still do not know which factor(s) needed to generate HSC
is still missing. However, recent publications using repro-
gramming of specified cells are starting to shed light on
this issue.24-26 It was recently reported that overexpression
of 5 factors in hESC-derived HPC confers short-term
engraftment potential to these hESC-derived cells.24 One
of the factors which was required for in vivo engraftment
was characterized as MYB. A similar strategy was used for
reprogramming murine hematopoietic cells toward trans-
plantable HSC.26 Although the reprogramming factors
needed for conferring HSC properties have not yet
reached consensus, this approach may prove to be an
alternative method for generating HSC from pluripotent
stem cells.
An alternative hypothesis could be that HSC are contin-
uously generated in vitro, but lack necessary signals that are
present in vivo, and thus quickly degenerate to restricted
precursor cells, losing their self-renewal capacity. Fetal,
newborn and adult HSC are known to lose the capacity to
self-renew within days of in vitro culture.27-29 
To study the emerging HPC in vitro, we isolated CD34+
CD43– endothelial cells and studied the characteristics of
hematopoietic cells generated from them through time-
lapse microscopy. We did not observe generation of MYB-
eGFP expressing cells that subsequently lose MYB expres-
sion in vitro. This is in line with the reported generation of
hematopoietic cells directly from hemogenic endothelium
from Myb–/– murine ESC, showing MYB to be dispensable
for endothelial to hematopoietic transition.30 Instead, we
observed either cells that remained MYB negative, or cells,
which up-regulated MYB over the course of several days
and were further characterized as granulocyte lineage
cells. In the murine system, strong evidence was provided
that MYB is essential for HSC function. Transplantable
HSC were shown to express high levels of Myb.6 This is
strengthened by the fact that Myb–/– mice die around fetal
d15 due to lack of transplantable HSC;4 moreover, condi-
tional deletion of Myb leads to exhaustion of the stem cell
pool and failure to engraft upon transplantation of LSK
cells.6 We can, therefore, conclude that it is unlikely that
HSC are generated in these spin EB cultures.
Conditional MYB knockout models show a marked
decrease in granulocytic development, suggesting an
important role for MYB in granulocytic development.7 In
addition, hematopoietic differentiation cultures set up
with Myb–/– murine ESC also showed defective granulo-
cyte lineage differentiation.30,31 Clarke et al. reported a sim-
ilar potential to generate CFU-E and CFU-M between
wild-type and Myb–/–mESC in short-term cultures; howev-
er, later on, the numbers of CFU-E and CFU-GM were
decreased. Sakamoto et al. compared wild-type with
Myb–/– mES cells and knock out mES cells that expressed
Myb under control of a tetracyclin-inducible promotor.
They reported similar numbers of hematopoietic cells gen-
erated by wild-type and knock-out cells, whereas induc-
tion of Myb during hematopoietic differentiation resulted
in vastly higher cell numbers. Similar to Clarke et al., they
report a reduced differentiation towards erythroid and
granulocytic lineages, whereas the monocytic differentia-
tion is unaffected. The relative absence of these lineages in
mESC cultures reflects the MYB dependency of a lineage
restricted erythroid-megakaryocytic and erythro-myeloid
precursor rather than the generation of MYB-dependent
HSC. These data thus point towards a differential require-
ment of MYB during macrophage/granulocyte commit-
ment, as is also apparent in our experiments.
Recent studies suggest that tissue macrophages belong
to a separate lineage derived from MYB-independent pre-
cursors. These are derived from YS-derived EMP and per-
sist by local proliferation of terminally differentiated cells
or precursors into adult life independent from the bone
marrow. The MYB-eGFP– macrophage cells generated in
our cultures, co-express CD14 and CD16, a phenotype
previously described for tissue macrophages.32,33 
In conclusion, we have shown that hematopoietic pre-
cursor cells that arise from endothelial cells in EB cultures
are MYB negative. MYB-positive precursors arise later in
the cultures and are granulocyte lineage restricted. These
data, therefore, provide evidence that bona fide HSC are
neither generated nor maintained in these cultures. Rather,
yolk sac-like hematopoietic precursors are formed. We
here describe that granulocytic lineage committed progen-
itor diverge thereof, and that this process is accompanied
by the upregulation of MYB expression. In this light, rein-
vestigation of Myb signal in YS precursors might be
advised. In addition, we have described a MYB reporter
cell line, which may be helpful to screen for conditions
that can generate HSC from hemogenic endothelium in
vitro.
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